Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-128-1 | CAS number: 68411-46-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The UVCB substance is a viscous liquid of mixed branched alkylated diphenylamines. Systemic uptake after ingestion is shown by effects on liver upon repeated gavage dosing with a solution in corn oil. This is consistent with a molecular weight of the components of the UVCB substance of 225 - 520 g/mol and calculated log Pow values of >4. All components offer functional group for xenobiotic metabolism and are not susceptible to stomach-acid catalysed hydrolysis. If sterically unhindered, the secondary amine may be conjugated. Also branched side chains may become oxidated. The technical function of the substance is to be an antioxidant in oil systems. The rate of metabolism and elimination will depend on the type of alkylation of the individual component. Emulgation via bile acids is expected to facilitate oral uptake compared to the dermal route of exposure. It is expected that gavage dosing in corn oil will result in higher systemic peak exposures compared to dermal exposure. Modelling of skin permeability based on Fitzpatrick et al. (Chemosphere 55 (2004) 1309–1314), the components are slightly to marginally permeable. The mixture is non volatile.
The substance causes an enlargement of liver that is accompanied by changes in histopathology and clinical chemistry. Some of the changes in clinical chemistry may be attributed to induction of xenobiotic metabolism in liver. An exemple is the increased rate of conjugation of bile acids and bilirubin. A secondary enlargement of thyroid is a known side effects in rats as xenobiotic enzymes also conjugate thyroid hormones.
Overall, the substance may only accumulate if the capacity for xenobiotic metabolism is in an overload situation.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
The multiconstituent substance consists of components sharing a diphenylamine core and differing in the number and location of branched C4 and C8 alkyl substitutents. The table below gives information on the substance itself and and on the branched nonyl-analogue.
For a figure with the representative components, it is referred to the robust study summary (7.1.1 Basic toxicokinetics), as it is technically not possible to show a picture in the endpoint summary.
Reaction products of benzeneamine, N-phenyl with nonene (branched) |
Reaction products of Benzenamine, N-phenyl with 2,4,4-trimethylpentene |
||
EC: 253-249-4 |
EC: 270-128-1 |
||
R = highly branched nonyl- (C9H19) |
R = tert-butyl or tert. octyl |
||
Sum of mono-nonyl-diphenylamine isomers
|
31.1% |
Tert.-butyl-diphenylamine |
14.3% |
MW=295 |
MW=225 |
||
C21H29N |
C16H19N |
||
Sum of dialkyl-diphenylamine isomers
|
62.4% |
Group A: sum of p- and o-substituted mono-tert. octyl or di-tert.butyl isomers |
35.3% |
MW=421 |
MW=281 |
||
C30H47N |
C20H27N |
||
|
|
Group B: sum of p- and o-substituted tert.-butyl-tert. octyl or di-tert.butyl-mono-tert. octyl isomers (may be either di- or trialkylated) |
32.0% |
|
MW=338 |
||
|
C24H35N |
||
|
|
Group C: p-di-tetramethylbutyl-diphenylenamine and isomers of p-or o-substituted tert-octyl isomers |
17.3% |
|
MW=394 |
||
- |
C28H43N |
||
Sum of tri-alkyl diphenylamine isomers |
2.2% |
Sum of tri-alkyl diphenylamine isomers |
0.3% + trialyl isomers of group B |
MW= 547 |
MW =449.77, or 505.88 or 337.55 |
||
C39H66N |
|
||
Sum of other mono- and poly-alkyl-diphe-nylamine isomers |
4.3% |
|
|
|
|||
|
With respect to molecular weight, the lipophilic character and the high log POW, it is expected that the UVCB substance is absorbed in the gastro-intestinal tract after oral administration. Indeed, effects on liver have been observed upon subacute dosing of fairly high doses (125 and 300 mg/kg bw). In another studies, non-adverse effects on liver were seen at 25 mg/kg bw and a LOAEL of 75 mg/kg bw was found. For the analogue substance extra investigations regarding potential methaemoglobin formation were included in the 90 -day study. Since the rate of Heinz bodies was not increased up to the limit dose (1000 mg/kg bw), the alkylated diphenylamines are considered to be inactive regarding methaemoglobin formation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.